Bright Minds Biosciences Inc. (DRUG)

CIK 1827401 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bright Minds Biosciences Inc..

Recent SEC filings

FiledFormAccession number
Aug 17, 20266-K0001062993-26-004442
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003688
Aug 13, 2026S-80001062993-26-004235
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004968
Jul 2, 2026SCHEDULE 13D/A0001062993-26-003506
Jun 3, 20266-K0001062993-26-003005
Jun 2, 20266-K0001062993-26-002975
May 28, 20266-K0002060755-26-000031
May 20, 20266-K0001062993-26-002801
May 15, 2026SCHEDULE 13G/A0001274173-26-000135
May 15, 2026SCHEDULE 13G/A0001274173-26-000134
May 15, 2026SCHEDULE 13G0000902664-26-002546
May 12, 2026SCHEDULE 13G/A0001213900-26-055371
Apr 30, 2026SCHEDULE 13G/A0000929638-26-001709
Apr 30, 202640000929638-26-001708
Feb 17, 2026SCHEDULE 13G/A0001193125-26-054519
Feb 17, 2026SCHEDULE 13G/A0001274173-26-000081
Feb 17, 2026SCHEDULE 13G/A0001831942-26-000007
Feb 13, 20266-K0001062993-26-000881
Feb 6, 2026SCHEDULE 13G/A0001172661-26-000518
Jan 9, 20266-K0001062993-26-000138
Jan 9, 2026424B50001062993-26-000136
Jan 9, 20266-K0001062993-26-000151
Jan 8, 20266-K0002060755-26-000009
Jan 7, 2026FWP0001062993-26-000098